An Israeli hospital on Monday began administering fourth coronavirus vaccine doses to a test group of health-care workers, in what it’s calling the world’s first trial of its kind, as the country weighs approval for a wider campaign for at-risk Israelis in efforts to stem the rapid spike in infections by the omicron variant.
The trial at Sheba Medical Center in central Israel involves 150 medical workers who received third doses before Aug. 20 and have antibody counts below 700, signifying low protection, according to a statement from the hospital. The trial is being carried out in conjunction with Israel’s Health Ministry.
“It’s one jab in the shoulder, but one giant leap for mankind,” said Jacob Levee, director of the hospital’s heart transplant unit and the first recipient of the fourth vaccine at Sheba.
He said that he wanted to get vaccinated to protect his heart transplant patients, whose “immunity following the third dose has diminished significantly, so they’re exposed,” according to research done at Sheba, he said.... Read More: Washington Post